先天性动静脉瘘的腔内治疗

Endovascular treatment of congenial arteriovenous fistula

目的探讨微创腔内治疗先天性动静脉瘘的有效性、安全性。方法回顾性分析我院2006年3月-2009年10月30例先天性动静脉瘘的临床资料,完善相关检查后行血管造影检查及腔内治疗术,术后每3个月进行随访。结果25例经腔内治疗后成功封堵或栓塞动静脉瘘,症状改善,无并发症和围手术期死亡。5例因术中无法配合、风险过大、血管过细微导管无法通过等原因未行治疗。平均随访6个月。随访期内5例症状复发,但较腔内治疗前轻。结论腔内治疗先天性动静脉瘘疗效明确、安全、微创,短期随访效果满意。

Objective To study the efficacy and safety of endovascular treatment of congenial arteriovenous fistula and its problems.Methods Clinical data about 30 congenial arteriovenous fistula patients admitted to our hospital in March 2006-October 2009 were retrospectively analyzed.The patients underwent angiography and endovascular surgical treatment after certain examinations and were followed up every three months after operation.Results The symptoms of 25 patients were improved after endovascular surgical treatment with no complications and peri-operative death occurred.Five patients were not treated due to their failure in cooperation or a high risk or too thin vessels.The patients were followed up for an average period of six months during which symptoms recurred in 5 patients.However,they were less severe than before treatment.Conclusion Endovascular treatment is an effective,safe and micro-invasive procedure for congenial arteriovenous fistula with a satisfactory short term outcome.